author-photo

Katie Tuckwell

Genentech
Hoffmann-La Roche

45

Papers

1053

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor, Fenebrutinib (GDC-0853), in Systemic Lupus Erythematosus.

2021 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (5)
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

2021 Intensive Care Medicine
Show All
- Source
- Cite
- Save
Citations (3)
OP0233 EFFICACY, SAFETY, AND PHARMACODYNAMIC EFFECTS OF THE BRUTON’S TYROSINE KINASE INHIBITOR, FENEBRUTINIB (GDC-0853), IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS IN A PHASE 2 CONTROLLED STUDY

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (7)
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study).

2020 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (34)
Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials.

2020 Rheumatology
Show All
- Source
- Cite
- Save
Citations (4)
Population Pharmacokinetics, Efficacy Exposure-Response Analysis

2020 Pharmaceutical Research
Show All
- Source
- Cite
- Save
Citations (5)
Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

2020 Pharmaceutical Research
Show All
- Source
- Cite
- Save
Citations (0)
Glucocorticoid Doses and Acute‐Phase Reactants at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

2019 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (38)
351. EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL

2019 Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

2019
Show All
- Source
- Cite
- Save
Citations (3)